NICE recommends Takhzyro

18 September 2019 - NICE - a health technology appraisal body in England and Wales - has recommended the use ...

Read more →

'A child's health should not be a postcode lottery': anger of cystic fibrosis sufferers forced to pay £20,000 for drug abroad

17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...

Read more →

News NHS England explores funding options for cystic fibrosis drug

17 September 2019 - NHS England is “committed to exploring and developing alternative routes” to enable people with cystic fibrosis ...

Read more →

Batten disease treatment: parents win battle ahead of court date

11 September 2019 - Families of children with a rare degenerative disease have won their fight for funding for NHS ...

Read more →

NICE publishes its 600th technology appraisal guidance

12 September 2019 - The guidance relates to the use of pembrolizumab in combination with carboplatin and paclitaxel on the ...

Read more →

Children with rare inherited condition to benefit from drug through managed access agreement

11 September 2019 - It is estimated that in the UK there are around 30 to 50 children living with the ...

Read more →

Government injects £130 million into cancer & debilitating illnesses

11 September 2019 - The UK government has announced an investment of over £130 million for new tech to tackle ...

Read more →

Subscription model for antibiotic development

6 September 2019 - An unlikely answer to the global crisis in antibiotic resistance. ...

Read more →

Will the UK run out of insulin and other vital medicines in a no-deal Brexit?

9 September 2019 - All but the most brazen companies aim to win their customers’ trust. But for businesses supplying ...

Read more →

NHS funds eye gene therapy, after Novartis cuts £613,000 price

4 September 2019 - NICE has recommended the NHS should fund Novartis’ Luxturna for a rare eye disorder, after the ...

Read more →

NICE recommends novel gene therapy treatment for rare inherited eye disorder

4 September 2019 - It's estimated that 86 people would be eligible for treatment with voretigene neparvovec in England. ...

Read more →

NHS saves more than £700 million on medicines costs

2 September 2019 - The NHS has announced that it has saved more than £700 million from the annual medicines ...

Read more →

NHS leaders warn of no-deal Brexit flu vaccine delays

30 August 2019 - A no-deal Brexit would make delays in the flu vaccine supply this year “likely”, according to ...

Read more →

Assessing the health effects of a “no deal” Brexit

29 August 2019 - Boris Johnson says that the UK will leave the EU on the 31 October 2019, “do ...

Read more →

Who could replace Sir Andrew Dillon at NICE?

28 August 2019 - With Sir Andrew Dillon announcing his retirement as chief executive of NICE, pharmaphorum discusses potential replacements ...

Read more →